A Phase II Randomised, Placebo-Controlled Trial of Low Dose (metronomic) Cyclophosphamide and Nintedanib (BIBF1120) in Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer
GYNECOLOGIC ONCOLOGY（2020）
关键词
Late stage relapsed ovarian cancer,Oral cyclophosphamide,Nintedanib,Prior bevacizumab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要